<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01966172</url>
  </required_header>
  <id_info>
    <org_study_id>Smerte1</org_study_id>
    <nct_id>NCT01966172</nct_id>
  </id_info>
  <brief_title>Multimodal Analgesic Treatment Versus Traditional Morphine Analgesia After Cardiac Surgery</brief_title>
  <official_title>Multimodal Opiate-sparing Analgesia Versus Traditional Opiate Based Analgesia After Cardiac Surgery, a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To test if multimodal analgesia with different analgesic medication offer better pain relief,
      lesser side effects and is safe compared to conventionel opiod analgesia after cardiac
      surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of analgesic effect by 11-NRS scale</measure>
    <time_frame>4th postoperative day</time_frame>
    <description>assessement of analgesic effect for the first 4 days after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Additional analgesic consumption</measure>
    <time_frame>4th postoperative day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay in days.</measure>
    <time_frame>days until discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of side-effects by daily questionnaire</measure>
    <time_frame>4th postoperative day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac complications</measure>
    <time_frame>30th postoperative day</time_frame>
    <description>i.e. Myocardial infarction(MI), postoperative pericardial effusion, heart failure requiring inotropic support , atrial fibrillation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other complications</measure>
    <time_frame>30th postoperative day</time_frame>
    <description>i.e. cerebral (stroke, bleeding), GI(bleeding), blood component requirements and sternal complications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 day Mortality</measure>
    <time_frame>30th postoperative day</time_frame>
    <description>Death from all causes.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Analgesia</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Multimodal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oral Ibuprofen 400mg 4 times daily oral Gabapentin 300mg twice daily oral Paracetamol 1000mg 4 times daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oral Morphine 10mg 4 times daily oral paracetamol 1000mg 4 times daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>oral ibuprofen 400mg 4 times daily</description>
    <arm_group_label>Multimodal</arm_group_label>
    <other_name>non-selective Non-steroid antiinflammatory drug (NSAID)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>Oral Gabapentin 300mg twice daily</description>
    <arm_group_label>Multimodal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>10 mg morphine orally 4 times daily</description>
    <arm_group_label>Morphine</arm_group_label>
    <other_name>An opiod</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <description>oral paracetamol 1000mg four times daily</description>
    <arm_group_label>Multimodal</arm_group_label>
    <arm_group_label>Morphine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt;18

          -  any cardiac procedure with sternotomy

          -  able to give informed consent

        Exclusion Criteria:

          -  cardiac surgery without sternotomy

          -  peripheral neuropathy

          -  neurological disease

          -  psychiatric illness

          -  history of GI bleeding

          -  chronic pain (i.e. back pain, cancer, arthritis)

          -  serum creatinine &gt;150 Î¼mol/l

          -  hepatic disease with elevated liver enzymes (SGPT and SGOT elevated to 1.5 times
             maximum normal value)

          -  allergic to study medication

          -  alcohol abuse

          -  abuse of narcotics or medication

          -  pregnancy

          -  participation in other clinical trials

          -  insufficient language skills

          -  In addition intensive care unit (ICU) stay for more than 24 hours was used as a
             pre-defined post randomization exclusion criteria, because prolonged ICU stay and
             ventilator treatment would interfere with study analgesic protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Skov Olsen, MD,PhD,DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sulman Rafiq, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet, Copenhagen University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2013</study_first_submitted>
  <study_first_submitted_qc>October 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2013</study_first_posted>
  <last_update_submitted>October 16, 2013</last_update_submitted>
  <last_update_submitted_qc>October 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Sulman Rafiq</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>NSAID, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
    <mesh_term>gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

